Institute for Materials Science and Max Bergmann Center of Biomaterials, Technische Universität Dresden, Budapester Str 27, 01069 Dresden, Germany.
J Biomed Mater Res A. 2010 Dec 1;95(3):848-56. doi: 10.1002/jbm.a.32856.
Bone remodeling and, therefore, integration of implant materials require the coordinated regulation of osteoblast and osteoclast activity. This is why the in vitro evaluation of biomaterials for bone regeneration should involve not only the analysis of osteoblast differentiation but also the formation and differentiation of osteoclasts. In the present study, we applied a material made of mineralized collagen I that mimics extracellular bone matrix to establish a culture system, which allows the cocultivation of human monocytes and human mesenchymal stem cells (hMSCs), which were differentiated into osteoclast-like cells and osteoblasts, respectively. Both cell types were cultivated on membrane-like structures from mineralized collagen. Transwell inserts were used to spatially separate the cell types but allowed exchange of soluble factors. The osteoclastogenesis and osteogenic differentiation were evaluated by analysis of gene expression, determination of alkaline phosphatase (ALP), and tartrate-resistant acidic phosphatase (TRAP) activity. Furthermore, cell morphology was studied using scanning electron and transmission electron microscopy. Osteogenically induced hMSC showed an increased specific ALP activity as well as increased gene expression of gene coding for alkaline phosphatase (ALPL), when cocultivated with differentiating osteoclasts. Adipogenic differentiation of hMSCs was suppressed by the presence of osteoclasts as indicated by a major decrease in adipocyte cell number and a decrease in gene expression of adipogenic markers. The formation of multinucleated osteoclasts seems to be decreased in the presence of osteogenically induced hMSC as indicated by electron microscopic evaluation and determination of TRAP activity. However, gene expression of osteoclast markers was not decreased in coculture with osteogenically induced hMSC.
骨重塑以及因此,植入材料的整合需要成骨细胞和破骨细胞活性的协调调节。这就是为什么用于骨再生的生物材料的体外评估不仅应包括成骨细胞分化的分析,还应包括破骨细胞的形成和分化。在本研究中,我们应用了一种模仿细胞外骨基质的矿化 I 型胶原制成的材料来建立一种培养体系,该体系允许人单核细胞和人间充质干细胞(hMSC)的共培养,它们分别分化为破骨样细胞和成骨细胞。这两种细胞类型都在矿化胶原的膜状结构上培养。Transwell 插入物用于在空间上分离细胞类型,但允许可溶性因子交换。通过分析基因表达、测定碱性磷酸酶(ALP)和抗酒石酸酸性磷酸酶(TRAP)活性来评估破骨细胞生成和成骨分化。此外,还使用扫描电子显微镜和透射电子显微镜研究了细胞形态。当与分化的破骨细胞共培养时,成骨诱导的 hMSC 显示出增加的特异性 ALP 活性以及编码碱性磷酸酶(ALPL)的基因表达增加。破骨细胞的存在抑制了 hMSC 的脂肪生成分化,这表现为脂肪细胞数量的显著减少和脂肪生成标志物的基因表达减少。电子显微镜评估和 TRAP 活性测定表明,成骨诱导的 hMSC 的存在似乎会降低多核破骨细胞的形成。然而,与成骨诱导的 hMSC 共培养时,破骨细胞标志物的基因表达并未降低。